Framework for FDA’s Real-World Evidence Program – Mar 15, 2019

Dr. Jacqueline Corrigan-Curay from FDA’s Office of Medical Policy speaks about how the agency will evaluate the use of real-world data to generate real world evidence for regulatory decisions. The webinar also discusses future plans for the RWE Program, which is part of the 21st Century Cures Act. Lastly, FDA will describe a demonstration project that will help inform the use of real world data and RWE. Learn more at https://www.fda.gov/drugs/webinar-fra....
_______________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Visit https://www.fda.gov/cdersbia and https://www.fda.gov/cdersbialearn for news and a repository of training activities.

Email: [email protected]
Phone: (301) 796-6707 I (866) 405-5367
LinkedIn:   / cder-small-business-and-industry-assistance  
Twitter:   / fda_drug_info  
CDER small business e-mail update subscription: https://updates.fda.gov/subscriptionm...